5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine hydrochloride, 95.0%, 5g

3-(DIBENZYLAMINO)AZEPAN-2-ONE, 95%, 250mg

Boc-N-Me-Val-OH, 95.0%, 25g

2-(Aminomethyl)cyclopentan-1-ol, 97%, 5g

Dimethyl[2-(phenylamino)ethyl]amine, 95%, 10g

tert-Butyl N-{4-aminobicyclo[2.1.1]hexan-1-yl}carbamate, 98%, 100mg

5-Bromo-3-(difluoromethyl)picolinic acid, 98%, 250mg

Methyl 5-(bromomethyl)-2-fluorobenzoate, 95.0%, 1g

tert-Butyl (4-((5-fluoro-7-(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)carbamate, 98%, 250mg

2-(4-methoxy-3-methylphenyl)acetyl chloride, 95.0%, 250mg

(R)-Indoline-2-carboxylic acid, 95.0%, 1g

2-(Methoxymethyl)pyrimidin-4-amine, 95.0%, 10g

Phase contrast slide set with 10x and S40x PLPHi IOS infinity corrected objectives and phase contrast rings for 10x/S40x